Carbonic anhydrase inhibitors: Inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides

Journal of Medicinal Chemistry

Volumn 50, Issue 7, 2007, Pages 1651-1657

  Wilkinson, Brendan L ^a   Bornaghi, Laurent F ^a   Houston, Todd A ^a   Innocenti, Alessio ^b   Vullo, Daniela ^b   Supuran, Claudiu T ^b   Poulsen, Sally Ann ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [(2',3',4',6' TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL)OXYMETHYL] 1H 1,2,3 TRIAZOL 1 YL]BENZENESULFONAMIDE; BENZENE DERIVATIVE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; SULFONAMIDE; TRIAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CYCLOADDITION; DIPOLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; EVALUATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE III; CARBONIC ANHYDRASE INHIBITORS; GALACTOSIDES; GLYCOSIDES; ISOENZYMES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; TRIAZOLES;

EID: 34147144592     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061320h     Document Type: Article

References (44)

1. Supuran, C. T. Carbonic anhydrases: Catalytic and inhibition mechanism, distribution and physiological roles. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C.T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 1-24.
2. Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Curr. Med. Chem.: Immunol. Endocr. Metab. Agents 2001, 1, 61-97.
3. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
4. Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran, C. T. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 2004, 19, 199-229.
5. Thiry, A.; Dogné, J. M.; Masereel, B.; Supuran, C. T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci. 2006, 27, 566-573.
6. Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and antiviral sulfonamides. Curr. Med. Chem. 2003, 10, 925-953.
7. Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C. T. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 869-873.
8. Pastorekova, S.; Pastorek, J. Cancer-related carbonic anhydrase isozymes. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C.T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 253-280.
9. Cecchi, A.; Taylor, S. D.; Liu, Y.; Hill, B.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 5192-5196.
10. Innocenti, A.; Antel, J.; Wurl, M.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. Bioorg. Med. Chem. Lett. 2004, 14, 5703-5707.
11. Supuran, C. T. Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin. Ther. Pat. 2003, 13, 1545-1550.
12. Nishimori, I.; Vullo, D.; Innocenti, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 3828-3833.
13. Parkkila, S.; Parkkila, A. K.; Rajaniemi, H.; Shah, G. N.; Grubb, J. H.; Waheed, A.; Sly, W. S. Expression of membrane-associated carbonic anhydrase XIV on neurons and axons in mouse and human brain. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1918-1923.
14. Reviewed in: Supuran, C. T.; Casini, A.; Scozzafava, A. Development of sulfonamide carbonic anhydrase inhibitors. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C.T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 67-148.
15. Erlanson, D. A.; McDowell, R. S.; O'Brien, T. Fragment-based drug discovery. J Med. Chem. 2004, 47, 3463-3482.
16. Zartler, E. R.; Shapiro, M. J. Fragonomics: Fragment-based drug discovery. Curr. Opin. Chem. Biol. 2005, 9, 366-270.
17. Svastova, E.; Hulikova, A.; Rafajova, M.; Zatovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C. T.; Pastorek, J.; Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577, 439-445.
18. Wykoff, C. C.; Beasley, N. J.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliff, P. J.; Harris, A. L Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000, 60, 7075-7083.
19. Parkkila, S.; Rajaniemi, H.; Parkkila, A. K.; Kivelä, J.; Waheed, A.; Pastoreková, S.; Pastorek, J.; Sly, W. S. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2220-2224.
20. Cecchi, A.; Hulikova, A.; Pastorek, J.; Pastorekova, S.; Scozzafava, A.; Winum, J.-Y.; Montera, J.-L.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J. Med. Chem. 2005, 48, 4834-4841.
21. Vullo, D.; Steffansen, B.; Brodin, B.; Supuran, C. T.; Scozzafava, A.; Nielsen, C. U. Carbonic anhydrase inhibitors: Transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters. Bioorg. Med. Chem. Lett. 2006, 14, 2418-2427.
22. Scozzafava, A.; Briganti, F.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J. Med. Chem. 2000, 43, 292-300.
23. Supuran, C. T.; Scozzafava, A.; Ilies, M. A.; Briganti, F. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes. J. Enzyme Inhib. 2000, 15, 381-401.
24. Wilkinson, B. L.; Bornaghi, L. F.; Houston, T. A.; Innocenti, A.; Supuran, C. T.; Poulsen, S.-A. A novel class of carbonic anhydrase inhibitors: Glycoconjugate benzene sulfonamides prepared by "click-tailing". J. Med. Chem. 2006, 49, 6539-6548.
25. Wilkinson, B. L.; Bornaghi, L. F.; Houston, T. A.; Innocenti, A.; Vullo, D.; Supuran, C. T.; Poulsen, S.-A. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Bioorg. Med. Chem. Lett. 2007, 17, 987-992.
26. Drinnan, N. B.; Vari, F. Aspects of the stability and bioavailability of carbohydrates and carbohydrate derivatives. Mini-Rev. Med. Chem. 2003, 3, 633-649.
27. Service, R. F. The best of both worlds? Science 2001, 291, 2342-2342.
28. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem., Int. Ed. 2002, 41, 2596-2599.
29. Tornøe, C. W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064.
30. Wilkinson, B. L.; Bornaghi, L. F.; Poulsen, S.-A.; Houston, T. A. Synthetic utility of glycosyl triazoles in carbohydrate chemistry. Tetrahedron 2006, 62, 8115-8125.
31. Kuijpers, B. H. M.; Groothuys, S.; Keereweer, A. R.; Quaedflieg, P. J. L. M.; Blaauw, R. H.; van Delft, F. L.; Rutjes, F. P. J. T. Expedient synthesis of triazole-linked glycosyl amino acids and peptides. Org. Lett. 2004, 6, 3123-3126.
32. Das, J.; Patil, S. N.; Awasthi, R.; Narasimhulu, C. P.; Trehan, S. An easy access to aryl azides from aryl amines under neutral conditions. Synthesis 2005, 11, 1801-1806.
33. Mereyala, H. B.; Gurrala, S. R. A highly diastereoselective, practical synthesis of allyl, propargyl 2,3,4,6-tetra-O-acetyl-β-D-gluco, β-D-galactopyranosides and allyl, propargyl heptaacetyl-β-D- lactosides. Carbohydr. Res. 1998, 307, 351-354.
34. Tietze, L. F.; Feuerstein, T.; Fecher, A.; Haunert, F.; Panknin, O.; Borchers, U.; Schuberth, I.; Alves, F. Proof of principle in the selective treatment of cancer by antibody-directed enzyme prodrug therapy: The development of a highly potent prodrug. Angew. Chem., Int. Ed. 2002, 41, 759-761.
35. Robinson, M. A.; Charlton, S. T.; Garnier, P.; Wang, X.-T.; Davis, S. S.; Perkins, A. C.; Frier, M.; Duncan, R.; Savage, T. J.; Wyatt, D. A.; Watson, S. A.; Davis, B. G. LEAPT: Lectin-directed enzyme-activated prodrug therapy. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 14527-14532.
36. Thomson, J. S.; Vogt, T. Glycosylated natural products. In Carbohydrate-Based Drug Discovery; Wong, C.-H., Ed.; Wiley VCH Press: Weinheim, Germany, 2003; pp 658-711.
37. Khalifah, R.G. The carbon dioxide hydration activity of carbonic anhydrase. J Biol Chem. 1971, 246, 2561-2573.
38. Winum, J.-Y.; Vullo, D.; Casini, A.; Montera, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. J. Med. Chem. 2003, 46, 5471-5477.
39. Winum, J.-Y.; Vullo, D.; Casini, A.; Montera, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
40. Cecchi, A.; Hulikova, A.; Pastorek, J.; Pastorekova, S.; Scozzafava, A.; Winum, J.-Y.; Montera, J.-L.; Supuran, C. T. Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis. J. Med. Chem. 2005, 48, 4834-484.
41. Casey, J. R.; Morgan, P. E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. 2004, 47, 2337-2347.
42. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
43. Hang, H. C.; Bertozzi, C. R. Chemoselective approaches to glycoprotein assembly. Acc. Chem. Res. 2001, 34, 727-736.
44. Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 2003, 13, 1005-1009.